Phase III clinical trials for Abdala vaccine candidate authorized
The Center for the State Control of Medicines, Equipment and Medical Devices (CECMED) announced last Thursday the approval of the Phase III Clinical Trial of the Abdala vaccine candidate, one of the five possible Cuban vaccines against the SARS-CoV-2 virus and the second to begin this phase, the Agencia Cubana de Noticias news Read more